Gennex Laboratories Limited (BOM:531739)
10.71
-0.09 (-0.83%)
At close: Jun 16, 2026
Revenue by Segment
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 |
Bulk Drugs, Biotech Products and Intermediates | 1.73B | 1.38B | 867.14M | 656.03M | 612.14M | |||||
Bulk Drugs, Biotech Products and Intermediates Growth | 25.26% | 59.03% | 32.18% | 7.17% | 2.62% | |||||
Total | 1.73B | 1.38B | 867.14M | 656.03M | 612.14M | |||||
Total Growth | 25.26% | 59.03% | 32.18% | 7.17% | 2.62% |
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 |
Algeria | 681.00K | 5.11M | - | - | |||||
Algeria Growth | -86.66% | - | - | - | |||||
Bangladesh | 1.52M | - | 3.16M | 5.46M | |||||
Bangladesh Growth | - | - | -42.12% | 15.55% | |||||
Colombia | 49.27M | 932.00K | 4.62M | 9.48M | |||||
Colombia Growth | 5186.48% | -79.84% | -51.24% | -44.16% | |||||
Czech Republic | 457.00K | 211.00K | - | - | |||||
Czech Republic Growth | 116.59% | - | - | - | |||||
Egypt | 52.01M | 20.30M | 57.33M | 73.22M | |||||
Egypt Growth | 156.14% | -64.59% | -21.70% | 6.92% | |||||
El Salvador | 25.16M | 7.70M | 9.21M | - | |||||
El Salvador Growth | 226.69% | -16.36% | - | - | |||||
Guatemala | 9.68M | 15.63M | 11.75M | 15.63M | |||||
Guatemala Growth | -38.04% | 32.97% | -24.84% | 52.29% | |||||
Mexico | 28.51M | - | 503.00K | - | |||||
Peru | 27.89M | 14.00M | 19.00M | 18.78M | |||||
Peru Growth | 99.27% | -26.33% | 1.17% | -23.76% | |||||
Russia | - | 4.30M | 456.00K | - | |||||
Russia Growth | - | 842.98% | - | - | |||||
Turkey | 162.00K | 179.00K | 484.00K | 347.00K | |||||
Turkey Growth | -9.50% | -63.02% | 39.48% | - | |||||
Thailand | 2.50M | 1.85M | - | - | |||||
Thailand Growth | 35.01% | - | - | - | |||||
UAE | 8.65M | 1.02M | - | - | |||||
UAE Growth | 747.31% | - | - | - | |||||
Vietnam | 109.25M | 95.67M | 88.98M | 44.41M | |||||
Vietnam Growth | 14.19% | 7.52% | 100.38% | -3.15% | |||||
India | 621.53M | 442.71M | 380.28M | 276.52M | |||||
India Growth | 40.39% | 16.42% | 37.52% | -22.05% | |||||
Brazil | 1.25M | 224.00K | - | - | |||||
Brazil Growth | 458.48% | - | - | - | |||||
Bolivia | 314.00K | - | - | - | |||||
China | - | 2.25M | - | - | |||||
Germany | 2.83M | 12.62M | 8.07M | 13.00M | |||||
Germany Growth | -77.58% | 56.43% | -37.95% | 33.04% | |||||
Iran | - | 187.00K | 6.89M | 6.05M | |||||
Iran Growth | - | -97.28% | 13.80% | -61.32% | |||||
Saudi Arabia | - | 5.92M | 3.61M | 2.60M | |||||
Saudi Arabia Growth | - | 63.89% | 39.15% | 65.50% | |||||
Spain | 4.13M | 37.18M | 41.95M | 109.89M | |||||
Spain Growth | -88.90% | -11.36% | -61.83% | 54846.50% | |||||
Belgium | - | - | 165.00K | 682.00K | |||||
Belgium Growth | - | - | -75.81% | - | |||||
Cuba | - | - | 12.69M | - | |||||
Swizerland | - | - | 690.00K | 32.02M | |||||
Swizerland Growth | - | - | -97.85% | - | |||||
Uruguay | - | - | 1.15M | 536.00K | |||||
Uruguay Growth | - | - | 114.74% | - | |||||
Canada | - | - | - | 726.00K | |||||
Kenya | - | - | - | 203.00K | |||||
Netherland | - | - | - | 326.00K | |||||
Singapore | - | - | - | 2.26M | |||||
Total | 945.78M | 667.99M | 650.98M | 612.14M | |||||
Total Growth | 41.59% | 2.61% | 6.35% | 2.62% |